The costs of developing treatments for Alzheimer's disease: A retrospective exploration

DISCUSSION: Measures to reduce expenditures while moving toward disease-modifying therapies that alleviate the rising burden of AD require continued investment from industry, government, and academia.PMID:34581499 | DOI:10.1002/alz.12450

Source: The Journal of Alzheimers Association - September 28, 2021 Category: Psychiatry Authors: Jeffrey L Cummings Dana P Goldman Nicholas R Simmons-Stern Eric Ponton Source Type: research